[Triplet anti-tumor therapy based on thymosin α-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].

Xiaoqian Fu, Yuxiang Wei, De‐Hua Zheng, Lin Zhou, Zhidong Zhu, Jiyong Song, Likui Feng, Guosheng DuPubMed 2015

Abstract

The triple anti-tumor therapy can significantly prolong the survival time of rats with liver cancer, decrease the cancer incidence rate and the level of serum AFP.
BibTeX
@inproceedings{fu2015triplet,
  author = {Xiaoqian Fu and Yuxiang Wei and De‐Hua Zheng and Lin Zhou and Zhidong Zhu and Jiyong Song and Likui Feng and Guosheng Du},
  title = {{[Triplet anti-tumor therapy based on thymosin α-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].}},
  booktitle = {PubMed},
  year = {2015},
}

Loading related content...

Figure